# Systemic Inflammatory Biomarkers in Ovarian Cancer

> **NCT06629831** · — · COMPLETED · sponsor: **Bakirkoy Dr. Sadi Konuk Research and Training Hospital** · enrollment: 90 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** group with complications
- **OTHER:** group without complications

## Key facts

- **NCT ID:** NCT06629831
- **Lead sponsor:** Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-09-27
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629831, "Systemic Inflammatory Biomarkers in Ovarian Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06629831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*